Abstract:
Medical compositions and methods of suppressing microbial virulence are provided. By suppressing virulence, administration and/or application of the medical compositions can be used to prevent, mitigate, or treat a microbial infection. More specifically, the medical compositions include a phosphonate-containing polymer. The phosphonate-containing polymers can suppress the expression of various virulence factors without destroying all microbes that may be present.
Abstract:
A block copolymer is provided that includes a first block having pendant phosphate and/or phosphonate groups and a second block that contains pendant poly(dialkylsiloxane) groups. Compositions containing the block copolymer as well as articles that include the block copolymer are also provided. The block copolymer can be used to provide a surface that is easy to clean and/or that is resistant to oil and grease without the use of fluorinated materials.
Abstract:
Zwitterionic copolymers, coating compositions (e.g., aqueous coating compositions and articles containing such copolymers, and methods of coating such coating compositions; wherein the copolymer includes: (a) first monomeric units derived from monomers of Formula (I) CH2═CR1—(CO)—X—R2—[-Q-R3—]n—Y (I) or salts thereof, wherein: R1 is hydrogen or methyl; X is oxy or —NH—; R2 is an alkylene optionally including catenary oxygen; R3 is an alkylene; Q is —(CO)O—, —NR4—(CO)—NR4—, or —(CO)—NR4—; R4 is hydrogen or alkyl; n is equal to 0 or 1; and Y is phosphonic acid, phosphonate, phosphoric acid, or phosphate; and (b) second monomeric units derived from monomers of Formula (II) CH2═CR1—(CO)—X—R2—[-Q-R3—]n—[NR5R6]+—R7—Z— (II) wherein: R1 is hydrogen or methyl; X is oxy or —NH—; R2 is alkylene optionally including catenary oxygen; R3 is alkylene; Q is —(CO)O—, —NR4—(CO)—NR4—, or —(CO)—NR4-; R4 is hydrogen or alkyl; n is equal to 0 or 1; R5 and R6 are each independently an alkyl, aryl, or a combination thereof, or R5 and R6 both combine with the nitrogen to which they are both attached to form a heterocyclic ring having 3 to 7 ring members; R7 is alkylene; and Z″ is carboxylate or sulfonate. CH2═CR1—(CO)—X—R2—[-Q-R3-]n—Y (I) CH2═CR1—(CO)—X—R2—[-Q-R3—]n—[NR5R6]+—R7—Z− (II)
Abstract:
A curable composition is provided comprising a urethane (meth)acrylate oligomer, a urethane (urea) phosphonate adhesion promoter, optionally reactive diluents, and an initiator. The use of the urethane (urea) phosphonate adhesion promotor provides better ageing stability and adhesion, as measured by T-peel adhesion test, than the use of other conventional adhesion promotors.
Abstract:
Multilayered polymer films are configured so that successive constituent layer packets can be delaminated in continuous sheet form from the remaining film. The films are compatible with known coextrusion manufacturing techniques, and can be made without adhesive layers between layer packets that are tailored to be individually peelable from the remainder of the film. Instead, combinations of polymer compositions are used to allow non-adhesive polymer layers to be combined such that irreversible delamination of the film is likely to occur at interfaces between layer packets pairs. Some of the polymer layers, including at least one embedded layer, comprise an antimicrobial agent, and these layers may be positioned at the front of each layer packet. After the antimicrobial layer of one layer packet has been used, the packet can be peeled away to expose a pristine antimicrobial layer of the next layer packet. The antimicrobial agent may be organic.
Abstract:
Film-forming gel compositions, useful in creating conformable and flexible gel bandages, can be formulate from a film-forming polymer, an amine-rich adhesion promoter, and a volatile solvent. The gel compositions form relatively thick films when dried on tissue, and can exhibit enhanced breathability to promote wound healing.
Abstract:
A process for separating aggregated proteins from monomeric proteins in a biological solution, the process including: providing at least one filter element having a contacting surface, wherein the filter element comprises filter media comprising: a porous substrate; and disposed on the porous substrate, a polymer comprising a hydrocarbon backbone and a plurality of pendant groups attached to the hydrocarbon backbone, wherein each of a first plurality of pendant groups comprises: (1) at least one acidic group or salt thereof; and (2) a spacer group that directly links the at least one acidic group or salt thereof to the hydrocarbon backbone by a chain of at least 6 catenated atoms; and allowing an initial biological solution to contact the contacting surface of the filter element N under conditions effective to separate the aggregated proteins from the monomeric proteins such that a final biological solution includes purified monomeric proteins.
Abstract:
Film forming gel compositions, useful in creating conformable and flexible gel bandages, can be formulate from a film forming polymer, a tackifier, and a volatile solvent. The film forming gels can also include antiseptics, cationic polymer coagulants, fillers, and other additives. The gel compositions form relatively thick films when dried on tissue, and can exhibit enhanced breathability to promote wound healing.
Abstract:
A curable composition is provided comprising a urethane (meth)acrylate oligomer, a urethane (urea) phosphonate ad-hesion promoter, optionally reactive diluents, and an initiator. The use of the urethane (urea) phosphonate adhesion promotor provides better ageing stability and adhesion, as measured by T-peel adhesion test, than the use of other conventional adhesion promotors.
Abstract:
Zwitterionic copolymers, coating compositions (e.g., aqueous coating compositions and articles containing such copolymers, and methods of coating such coating compositions; wherein the copolymer includes: (a) first monomeric units derived from monomers of Formula (I) CH2═CR1—(CO)—X—R2—[-Q-R3—]n—Y (I) or salts thereof, wherein: R1 is hydrogen or methyl; X is oxy or —NH—; R2 is an alkylene optionally including catenary oxygen; R3 is an alkylene; Q is —(CO)O—, —NR4—(CO)—NR4—, or —(CO)—NR4—; R4 is hydrogen or alkyl; n is equal to 0 or 1; and Y is phosphonic acid, phosphonate, phosphoric acid, or phosphate; and (b) second monomeric units derived from monomers of Formula (II) CH2═CR1—(CO)—X—R2—[-Q-R3—]n—[NR5R6]+—R7—Z— (II) wherein: R1 is hydrogen or methyl; X is oxy or —NH—; R2 is alkylene optionally including catenary oxygen; R3 is alkylene; Q is —(CO)O—, —NR4—(CO)—NR4—, or —(CO)—NR4-; R4 is hydrogen or alkyl; n is equal to 0 or 1; R5 and R6 are each independently an alkyl, aryl, or a combination thereof, or R5 and R6 both combine with the nitrogen to which they are both attached to form a heterocyclic ring having 3 to 7 ring members; R7 is alkylene; and Z″ is carboxylate or sulfonate. CH2═CR1—(CO)—X—R2—[-Q-R3-]n—Y (I) CH2═CR1—(CO)—X—R2—[-Q-R3—]n—[NR5R6]+—R7—Z− (II)